[go: up one dir, main page]

DE69734141D1 - PROTEIN, DAS FÜR MENSCHLICHE Th2-ZELLEN SPEZIFISCH IST, DAFÜR KODIERENDES GEN UND KORRESPONDIERENDE TRANSFORMANTE, REKOMBINANTER VEKTOR UND MONOKLONALER ANTKÖRPER - Google Patents

PROTEIN, DAS FÜR MENSCHLICHE Th2-ZELLEN SPEZIFISCH IST, DAFÜR KODIERENDES GEN UND KORRESPONDIERENDE TRANSFORMANTE, REKOMBINANTER VEKTOR UND MONOKLONALER ANTKÖRPER

Info

Publication number
DE69734141D1
DE69734141D1 DE69734141T DE69734141T DE69734141D1 DE 69734141 D1 DE69734141 D1 DE 69734141D1 DE 69734141 T DE69734141 T DE 69734141T DE 69734141 T DE69734141 T DE 69734141T DE 69734141 D1 DE69734141 D1 DE 69734141D1
Authority
DE
Germany
Prior art keywords
cells
human
monoclonal antibodies
recombinant vector
coding gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69734141T
Other languages
English (en)
Other versions
DE69734141T2 (de
Inventor
Kazuyuki Ogawa
Kazuya Tanaka
Kinya Nagata
Syoichi Takano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BML Inc
Original Assignee
BML Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BML Inc filed Critical BML Inc
Publication of DE69734141D1 publication Critical patent/DE69734141D1/de
Application granted granted Critical
Publication of DE69734141T2 publication Critical patent/DE69734141T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DE69734141T 1996-06-05 1997-06-05 PROTEIN, DAS FÜR MENSCHLICHE Th2-ZELLEN SPEZIFISCH IST, DAFÜR KODIERENDES GEN UND KORRESPONDIERENDE TRANSFORMANTE, REKOMBINANTER VEKTOR UND MONOKLONALER ANTKÖRPER Expired - Lifetime DE69734141T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP16679396 1996-06-05
JP16679396 1996-06-05
PCT/JP1997/001906 WO1997046677A1 (fr) 1996-06-05 1997-06-05 PROTEINE SPECIFIQUE DU Th2 HUMAIN, GENE (B19) CODANT POUR CETTE PROTEINE, TRANSFORMANT, VECTEUR DE RECOMBINAISON ET ANTICORPS MONOCLONAL S'Y RAPPORTANT

Publications (2)

Publication Number Publication Date
DE69734141D1 true DE69734141D1 (de) 2005-10-13
DE69734141T2 DE69734141T2 (de) 2006-07-13

Family

ID=15837785

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69734141T Expired - Lifetime DE69734141T2 (de) 1996-06-05 1997-06-05 PROTEIN, DAS FÜR MENSCHLICHE Th2-ZELLEN SPEZIFISCH IST, DAFÜR KODIERENDES GEN UND KORRESPONDIERENDE TRANSFORMANTE, REKOMBINANTER VEKTOR UND MONOKLONALER ANTKÖRPER

Country Status (5)

Country Link
US (2) US6040426A (de)
EP (1) EP0851030B9 (de)
JP (1) JP3144805B2 (de)
DE (1) DE69734141T2 (de)
WO (1) WO1997046677A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2775984B1 (fr) * 1998-03-11 2006-09-15 Bioscreen Therapeutics Sa Criblage differentiel qualitatif
WO1999025734A2 (en) * 1997-11-13 1999-05-27 Schering Corporation Th2 CELL DEPLETION; COMPOSITIONS; METHODS
EP1119253A4 (de) * 1998-10-07 2005-12-21 Millennium Pharm Inc Th2-spezifische moleküle und ihre verwendung
ATE315230T1 (de) * 1999-08-23 2006-02-15 Bml Inc Verfahren zum identifizieren von prostaglandin d2 rezeptor modulatoren
WO2003030616A2 (en) * 2001-10-10 2003-04-17 Millennium Pharmaceuticals, Inc. 21132, a human g-protein coupled receptor family member and uses therefor
GB0324763D0 (en) 2003-10-23 2003-11-26 Oxagen Ltd Use of compounds in therapy
WO2005093092A2 (en) * 2004-03-26 2005-10-06 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 44 (gpr44)
KR20090042808A (ko) 2006-07-22 2009-04-30 옥사겐 리미티드 씨알티에이치2 길항제 활성을 갖는 화합물
EP2250161B1 (de) 2008-01-18 2013-10-16 Atopix Therapeutics Limited Verbindungen mit crth2-antagonisten-wirkung
US8168673B2 (en) 2008-01-22 2012-05-01 Oxagen Limited Compounds having CRTH2 antagonist activity
GB201103837D0 (en) 2011-03-07 2011-04-20 Oxagen Ltd Amorphous (5-Fluoro-2-Methyl-3-Quinolin-2-Ylmethyl-Indol-1-Yl)-acetic acid
GB201322273D0 (en) 2013-12-17 2014-01-29 Atopix Therapeutics Ltd Process
GB201407820D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
GB201407807D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
CN104992408B (zh) * 2015-06-30 2018-06-05 百度在线网络技术（北京）有限公司 用于用户终端的全景图像生成方法和装置
WO2017010567A1 (ja) * 2015-07-15 2017-01-19 協和発酵キリン株式会社 ヒトｃｒｔｈ２に特異的に結合する抗体
WO2018139404A1 (ja) 2017-01-24 2018-08-02 協和発酵キリン株式会社 放射線障害の治療又は予防剤並びに治療又は予防方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6066322A (en) * 1995-03-03 2000-05-23 Millennium Pharmaceuticals, Inc. Methods for the treatment of immune disorders

Also Published As

Publication number Publication date
US6166186A (en) 2000-12-26
JP3144805B2 (ja) 2001-03-12
US6040426A (en) 2000-03-21
EP0851030B1 (de) 2005-09-07
EP0851030A4 (de) 2002-05-15
EP0851030A1 (de) 1998-07-01
DE69734141T2 (de) 2006-07-13
EP0851030B9 (de) 2007-10-31
WO1997046677A1 (fr) 1997-12-11

Similar Documents

Publication Publication Date Title
DE69734141D1 (de) PROTEIN, DAS FÜR MENSCHLICHE Th2-ZELLEN SPEZIFISCH IST, DAFÜR KODIERENDES GEN UND KORRESPONDIERENDE TRANSFORMANTE, REKOMBINANTER VEKTOR UND MONOKLONALER ANTKÖRPER
ATE318912T1 (de) Polynukleotid kodierend für ein polypeptid mit heparanase-aktivität und dessen expression in transduzierten zellen
HUP9802212A3 (en) Recombinant anti-cd4 antibodies for human therapy
PL330935A1 (en) Polypeptide of 106 protein of moraxella catarrhalis outer membrane, gene sequence and their application
DE59813875D1 (de) Ko-stimulierendes polypeptid von t-zellen, monoklonale antikörper sowie die herstellung und deren verwendung
TR199900666T2 (xx) �nsan paratormonu ile ilgili peptidlere kar�� antikor.
NZ502392A (en) Interleukin-18 binding proteins (IL-18BP) their preparation and use in pharmaceuticals
AU3501197A (en) Human stem cell antigens, dna coding therefor and their use
EP1019028A4 (de) Chlamydiaprotein, gensequenz und deren verwendungen
DE69822307D1 (de) Menschliches adamts-1 protein, gen , welches für dieses kodiert, pharmazeutische zusammensetzung und verfahrem zur immunologischen bestimmung von menschlichen adamts-1 proteinen
NO910982L (no) Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller.
SG52342A1 (en) T cell antigen receptor v region protein and methos of preparation thereof
EP0911397A4 (de) Tumorantigenproteine, deren gene, sowie tumorantigenpeptide
IT1291135B1 (it) Vettori ricombinanti utilizzabili in terapia genica
EP0772691A4 (de) Vektoren und transformierte wirtszellen für die herstellung von rekombinanten proteinen bei verminderten temperaturen
HUP9902150A3 (en) Recombinant adenoviral vectors for human tumour gene therapy
NO971448D0 (no) Anti-Fas rekombinante antistoffer og DNA derfor
ZA9410217B (en) Recombinant human thymopoietin proteins and uses therefor.
DE19681160D2 (de) Polypeptide mit IL-16-Aktivität, Verfahren zu ihrer Herstellung und Verwendung
ATE202570T1 (de) Gene, die für macif proteine kodieren, expressionsvektoren mit diesem genen, und transformantenzellen mit diesem proteinen
EP1181315A4 (de) VON LAWSONIA ABSTAMMENDE GENE UND VERWANDTE F1gE POLYPEPTIDE, PEPTIDE UND PROTEINE UND IHRE VERWENDUNGEN
IL108781A0 (en) Chemeric human interferon-z receptor/immunoglobulin polypeptides, dna sequences coding for these polypeptides and their production
EP1044216A4 (de) DNS-MOLEKÜLE, DIE FÜR DIE MENSCHLICHEN KERNREZPTOR-PROTEINE nNR7 UND nNR7-1 KODIEREN.
DE19780377D2 (de) Prozessierte Polypeptide mit IL-16-Aktivität, Verfahren zu ihrer Herstellung und Verwendung
AU2176997A (en) Novel fused protein, gene therefor, recombinant vector, recombinant virus, and its use

Legal Events

Date Code Title Description
8364 No opposition during term of opposition